Bristol Myers, insitro extend ALS drug research dealnews2025-10-14T11:00:40+00:00October 14th, 2025|Endpoints News|
Takeda, Nabla Bio sign second research deal for AI-made proteinsnews2025-10-14T09:00:52+00:00October 14th, 2025|Endpoints News|
In the Lab: How Amgen sees AI changing pharma R&Dnews2025-10-08T14:00:50+00:00October 8th, 2025|Endpoints News|
Post-Hoc Live: Vijay Pande talks AI bio, starting new fund VZVC after a16znews2025-10-07T11:00:09+00:00October 7th, 2025|Endpoints News|
Epic embraces the newfound attention of its AI toolsnews2025-09-25T13:00:26+00:00September 25th, 2025|Endpoints News|
Endpoints 11 winner 2025: Chai Discovery aims to design drugs on the computernews2025-09-19T14:00:57+00:00September 19th, 2025|Endpoints News|
Endpoints 11 winner 2025: Lila Sciences will let ‘scientific superintelligence’ run the labnews2025-09-19T14:00:05+00:00September 19th, 2025|Endpoints News|
AI biotech Synthesize Bio launches with $10M seed roundnews2025-09-16T11:00:27+00:00September 16th, 2025|Endpoints News|
AI startup Lila Sciences raises $235M Series Anews2025-09-15T15:23:38+00:00September 15th, 2025|Endpoints News|
Lila Sciences is near a $300M+ fundraise to back autonomous science: sourcenews2025-09-13T16:31:09+00:00September 13th, 2025|Endpoints News|
